Groupama Asset Managment Purchases 187 Shares of The Clorox Company $CLX

Groupama Asset Managment grew its position in shares of The Clorox Company (NYSE:CLX) by 1.6% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 12,198 shares of the company’s stock after purchasing an additional 187 shares during the period. Groupama Asset Managment’s holdings in Clorox were worth $1,784,000 at the end of the most recent reporting period.

Several other institutional investors have also recently modified their holdings of CLX. Wood Tarver Financial Group LLC bought a new stake in Clorox in the 4th quarter worth approximately $31,000. GW&K Investment Management LLC raised its stake in shares of Clorox by 239.1% during the first quarter. GW&K Investment Management LLC now owns 295 shares of the company’s stock worth $43,000 after acquiring an additional 208 shares in the last quarter. Roble Belko & Company Inc raised its stake in shares of Clorox by 140.7% during the first quarter. Roble Belko & Company Inc now owns 361 shares of the company’s stock worth $53,000 after acquiring an additional 211 shares in the last quarter. Menard Financial Group LLC bought a new stake in shares of Clorox in the 4th quarter worth approximately $63,000. Finally, IMA Advisory Services Inc. purchased a new stake in shares of Clorox in the 1st quarter valued at $58,000. 78.53% of the stock is currently owned by institutional investors.

Clorox Stock Performance

Shares of CLX opened at $120.78 on Wednesday. The company has a 50-day simple moving average of $124.56 and a two-hundred day simple moving average of $135.95. The company has a debt-to-equity ratio of 5.15, a current ratio of 0.84 and a quick ratio of 0.57. The firm has a market capitalization of $14.77 billion, a PE ratio of 18.52, a price-to-earnings-growth ratio of 0.96 and a beta of 0.49. The Clorox Company has a one year low of $117.35 and a one year high of $171.37.

Clorox (NYSE:CLX) last posted its earnings results on Thursday, July 31st. The company reported $2.87 earnings per share for the quarter, topping analysts’ consensus estimates of $2.24 by $0.63. The firm had revenue of $1.99 billion for the quarter, compared to the consensus estimate of $1.94 billion. Clorox had a return on equity of 377.86% and a net margin of 11.40%.The business’s revenue for the quarter was up 4.5% on a year-over-year basis. During the same quarter in the prior year, the business earned $1.82 EPS. Clorox has set its FY 2026 guidance at 5.950-6.30 EPS. On average, analysts anticipate that The Clorox Company will post 7.15 EPS for the current fiscal year.

Clorox Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, August 29th. Shareholders of record on Wednesday, August 13th will be given a dividend of $1.24 per share. This is an increase from Clorox’s previous quarterly dividend of $1.22. This represents a $4.96 annualized dividend and a yield of 4.1%. The ex-dividend date of this dividend is Wednesday, August 13th. Clorox’s payout ratio is 76.07%.

Wall Street Analyst Weigh In

CLX has been the topic of a number of analyst reports. Morgan Stanley decreased their target price on shares of Clorox from $150.00 to $137.00 and set an “equal weight” rating on the stock in a research report on Friday, August 1st. UBS Group decreased their price objective on Clorox from $150.00 to $134.00 and set a “neutral” rating on the stock in a report on Thursday, July 17th. Barclays dropped their target price on Clorox from $129.00 to $119.00 and set an “underweight” rating for the company in a report on Tuesday, July 15th. Jefferies Financial Group decreased their price target on Clorox from $167.00 to $145.00 and set a “buy” rating on the stock in a research note on Thursday, June 26th. Finally, Evercore ISI set a $140.00 price objective on Clorox and gave the company an “underperform” rating in a research report on Tuesday, May 6th. One analyst has rated the stock with a Buy rating, eight have assigned a Hold rating and three have assigned a Sell rating to the stock. Based on data from MarketBeat, Clorox currently has an average rating of “Reduce” and a consensus price target of $143.36.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.